Yoon, Seung Kew

Publishing since 1993 (Senior)

Has published 96 publications in 18 years

Number of publications published per year by Yoon, Seung Kew. (Source : PubMed)

Distribution of publications types for Yoon, Seung Kew. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Yoo C, Ryu MH, Kang BW, Yoon SK, Ryoo BY, Chang HM, Lee JL, Beck MY, Kim TW, Kang YK. Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.  J. Clin. Oncol.  2010;28;9  
•  Yuen MF, Han KH, Um SH, Yoon SK, Kim HR, Kim J, Kim CR, Lai CL. Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease.  Hepatology  2010;51;3  
•  Woo HY, Jang JW, Choi JY, Bae SH, You CR, Rha SE, Lee YJ, Yoon SK, Lee CD. Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma.  Scand. J. Gastroenterol.  2010;45;3  
•  Jang JW, You CR, Kim CW, Bae SH, Yoon SK, Yoo YK, Kim DG, Choi JY. Benefit of downsizing hepatocellular carcinoma in a liver transplant population.  Aliment. Pharmacol. Ther.  2010;31;3  
•  Lee SY, Kwon HJ, Cho JH, Oh JY, Nam KJ, Lee JH, Yoon SK, Kang MJ, Jeong JS. Actinomycosis of the appendix mimicking appendiceal tumor: a case report.  World J. Gastroenterol.  2010;16;3  
•  Kwon JH, Choi JY, Jang JW, Bae SH, Yoon SK, Yang JM, Han NI, Lee CD, Lee YS, Chung KW. Impact of serial hepatitis B virus DNA on hepatocellular carcinoma development in patients with liver cirrhosis.  Intervirology  2010;53;2  
•  Kim JD, Choi JY, Bae SH, Yoon SK, Yang JM, Han NI, Choi SW, Lee CD, Lee YS, Jung ES. Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis.  Clin. Gastroenterol. Hepatol.  2010;8;1  
•  Kim JD, Choi JY, Kwon JH, Jang JW, Bae SH, Yoon SK, You YK, Kim DG. Performance of posttransplant Model for End-Stage Liver Disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation.  Transplant. Proc.  2009;41;9  
•  Kwon JH, Bae SH, Choi JY, Yoon SK, Byun KS, Paik SW, Lim YS, Lee HC, Han KH, Lee KS. Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C.  Korean J. Intern. Med.  2009;24;3  
•  Jeong SW, Kim JD, Woo HY, You CR, Lee SW, Song MJ, Jang JW, Bae SH, Choi JY, Yoon SK. Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.  The Korean journal of hepatology  2009;15;3  

[ See timeline ] [ See all publications ]